CREG Protects Retinal Ganglion Cells loss and Retinal Function Impairment Against ischemia-reperfusion Injury in mice via Akt Signaling Pathway

[1] Steinmetz JD(2021)Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to Sight: an analysis for the global burden of Disease Study Lancet Glob Health 9 e144-e160

[2] Bourne RRA(2019)Glaucoma and blood pressure Hypertension 73 944-950

[3] Briant PS(2021)Glaucoma Med Clin North Am 105 493-510

[4] Leeman M(2020)Glaucoma as a neurodegenerative Disease caused by intrinsic vulnerability factors Prog Neurobiol 193 101817-1035

[5] Kestelyn P(2019)From Ganglion cell to photoreceptor layer: Timeline of Deterioration in a rat Ischemia/Reperfusion model Front Cell Neurosci 13 174-5041

[6] Kang JM(2018)Glaucoma pathogenesis and neurotrophins: focus on the Molecular and genetic basis for therapeutic prospects Curr Neuropharmacol 16 1018-2128

[7] Tanna AP(1998)A cellular repressor of E1A-stimulated genes that inhibits activation by E2F Mol Cell Biol 18 5032-410

[8] Artero-Castro A(2000)The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells Oncogene 19 2120-313

[9] Rodriguez-Jimenez FJ(2016)Up-Regulation of CREG expression by the transcription factor GATA1 inhibits high glucose- and high Palmitate-Induced apoptosis in human umbilical vein endothelial cells PLoS ONE 11 e0154861-160

[10] Jendelova P(2020)Recombinant Cellular Repressor of E1A-Stimulated genes protects against Renal Fibrosis in Dahl Salt-Sensitive rats Am J Nephrol 51 401-607

[1] Steinmetz JD(2021)Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to Sight: an analysis for the global burden of Disease Study Lancet Glob Health 9 e144-e160

[2] Bourne RRA(2019)Glaucoma and blood pressure Hypertension 73 944-950

[3] Briant PS(2021)Glaucoma Med Clin North Am 105 493-510

[4] Leeman M(2020)Glaucoma as a neurodegenerative Disease caused by intrinsic vulnerability factors Prog Neurobiol 193 101817-1035

[5] Kestelyn P(2019)From Ganglion cell to photoreceptor layer: Timeline of Deterioration in a rat Ischemia/Reperfusion model Front Cell Neurosci 13 174-5041

[6] Kang JM(2018)Glaucoma pathogenesis and neurotrophins: focus on the Molecular and genetic basis for therapeutic prospects Curr Neuropharmacol 16 1018-2128

[7] Tanna AP(1998)A cellular repressor of E1A-stimulated genes that inhibits activation by E2F Mol Cell Biol 18 5032-410

[8] Artero-Castro A(2000)The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells Oncogene 19 2120-313

[9] Rodriguez-Jimenez FJ(2016)Up-Regulation of CREG expression by the transcription factor GATA1 inhibits high glucose- and high Palmitate-Induced apoptosis in human umbilical vein endothelial cells PLoS ONE 11 e0154861-160

[10] Jendelova P(2020)Recombinant Cellular Repressor of E1A-Stimulated genes protects against Renal Fibrosis in Dahl Salt-Sensitive rats Am J Nephrol 51 401-607